Crossmark

Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation

Published Online: 2021-02-08

Published Print: 2021-12

Authors

Hernæs, Kjersti Helene

Smeland, Knut B.

Fagerli, Unn-Merete

Kiserud, Cecilie E.
Funding

Funding for this research was provided by:

Helse Sør-Øst RHF (2011098, 2011036)
License Information

Text and Data Mining valid from 2021-02-08

Version of Record valid from 2021-02-08
More Information

Article History

Received: 25 August 2020

Accepted: 26 January 2021

First Online: 8 February 2021

Ethics approval and consent to participate

: The Regional Committee for Medical and Health Research Ethics of South-East Norway approved the study, including permission to access the raw data used in the study to source the participants. (2011/1353B). Informed consent was obtained from all individual participants included in the study. This article does not contain any studies with animals performed by any of the authors.

: Not applicable.

: KHH declares that she has no conflict of interest. KBS declares that he has no conflict of interest. UMF has been on the Advisory Board for Roche and Takeda but declares that she has no conflict of interest in this study. CEK declares that she has no conflict of interest.

Document is current